Cargando…

SEM Observation of the Filter after Administration of Blinatumomab: A Possibility of Leakage during Home Administration Using a Portable Infusion Pump

Blinatumomab (Blincyto(®) injection solution) is classified as a bispecific T-cell engaging (BiTE) antibody and is intended for the treatment of relapsed/refractory acute lymphoblastic leukemia. It requires continuous infusion to maintain therapeutic levels. Therefore, it is often administered at ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takano, Megumi, Inoue, Motoki, Ikeda, Yuko, Kage, Hidenori, Inokawa, Tohru, Nakadate, Kazuhiko, Yasu, Takeo, Tsuda, Yasumasa, Goto, Kazumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052184/ https://www.ncbi.nlm.nih.gov/pubmed/36982821 http://dx.doi.org/10.3390/ijms24065729

Ejemplares similares

Portable Automated Oxygen Administration System for hypoxaemic patients
por: Alzoubi, Khawla, et al.
Publicado: (2016)

Blinatumomab-associated vasculitis
por: Liau, MeiQi May, et al.
Publicado: (2017)

A Primer on Home Infusion Administration Methods
por: Loriaux, Alain, et al.
Publicado: (2022)

Meropenem administration by intermittent infusion versus continuous infusion for the treatment of nosocomial pneumonia
por: Lorente, L, et al.
Publicado: (2005)

Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma
por: Smith, Jasmine, et al.
Publicado: (2021)

Administration of 3% Sodium Chloride and Local Infusion Reactions
por: Moritz, Michael L., et al.
Publicado: (2022)

Effects of the Topical Administration of Semaglutide on Retinal Neuroinflammation and Vascular Leakage in Experimental Diabetes
por: Simó, Rafael, et al.
Publicado: (2021)

Blinatumomab in Relapsed/Refractory Burkitt Lymphoma
por: Bohler, Jeanne, et al.
Publicado: (2022)

Combination of Donor Lymphocyte Infusion and Blinatumomab for B-Cell Lymphoblastic Lymphoma Relapse after Allogeneic Stem-Cell Transplantation
por: Mori, Jinichi, et al.
Publicado: (2023)

Protocol for a randomised crossover trial to evaluate patient and nurse satisfaction with electronic and elastomeric portable infusion pumps for the continuous administration of antibiotic therapy in the home: the Comparing Home Infusion Devices (CHID) study
por: Hobbs, Jodie G, et al.
Publicado: (2017)

Real-World Multicenter Experience in Tumor Debulking Prior to Blinatumomab Administration in Adult Patients With Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
por: Bonifacio, Massimiliano, et al.
Publicado: (2022)

Survey of Anaphylaxis during Rasburicase Re-Administration in Patients with Hematological Malignancies Using a Japanese Claims Database
por: Kobayashi, Shunsuke, et al.
Publicado: (2022)

Replacement of oxytocin bolus administration by infusion: influences on postpartum outcome
por: Löytved-Hardegg, Julia J., et al.
Publicado: (2015)

Suitability of Amoxicillin–Clavulanic Acid for Administration via Prolonged Infusion
por: Fawaz, Sarah, et al.
Publicado: (2020)

Is routine replacement of i.v. administration sets required after each change of intermittently administrated antibiotic infusions?
por: von Au, Felix, et al.
Publicado: (2013)

Clinical Administration Characteristics of Subcutaneous and Intravenous Administration of Daratumumab in Patients With Multiple Myeloma at Mayo Clinic Infusion Centers
por: Soefje, Scott A., et al.
Publicado: (2023)

Subcutaneous vitamin B12 administration using a portable infusion pump in cobalamin-related remethylation disorders: a gentle and easy to use alternative to intramuscular injections
por: Lotz-Havla, Amelie S., et al.
Publicado: (2021)

Advancements in Therapy for Acute Lymphoblastic Leukemia: Blinatumomab
por: Hladnik,1, Lindsay, et al.
Publicado: (2016)

Blinatumomab in Ph+ B-ALL: present and perspectives
por: Papayannidis, Cristina, et al.
Publicado: (2017)

Recent advances on blinatumomab for acute lymphoblastic leukemia
por: Zhao, Juanjuan, et al.
Publicado: (2019)

Cytokine Release Syndrome Following Blinatumomab Therapy
por: Ojemolon, Pius E, et al.
Publicado: (2022)

Therapy with teicoplanin in the ICU: continuous intravenous infusion or intermittent intravenous administration?
por: Nardi, E, et al.
Publicado: (2008)

Comparison of the Ability of Two Brands of CBCT with That of SEM to Detect the Marginal Leakage of Class V Composite Resin Restorations
por: Karbasi Kheir, Mitra, et al.
Publicado: (2021)

Performance of a linear peristaltic infusion pump during red blood cells administration and the influence of infusion rates
por: Kusahara, DM, et al.
Publicado: (2015)

Biomarkers associated with blinatumomab outcomes in acute lymphoblastic leukemia
por: Wei, Andrew H., et al.
Publicado: (2021)

Relapse and Resistance to CAR-T Cells and Blinatumomab in Hematologic Malignancies
por: Jacoby, Elad
Publicado: (2019)

User preference for a portable syringe pump for iloprost infusion
por: Laria, Antonella, et al.
Publicado: (2015)

Understanding IV antimicrobial drug losses: the importance of flushing infusion administration sets
por: Bolla, Balwinder, et al.
Publicado: (2020)

Implementation of barcode medication administration (BMCA) technology on infusion pumps in the operating rooms
por: Hogerwaard, Manon, et al.
Publicado: (2023)

Affordable, portable and self-administrable electrical impedance tomography enables global and regional lung function assessment
por: Zouari, Fedi, et al.
Publicado: (2022)

Infectious Risks and Complications in Adult Leukemic Patients Receiving Blinatumomab
por: So, Wonhee, et al.
Publicado: (2018)

Pharmacokinetic and Pharmacodynamic Relationship of Blinatumomab in Patients with Non-Hodgkin Lymphoma
por: Hijazi, Youssef, et al.
Publicado: (2018)

Population Pharmacokinetics of Blinatumomab in Pediatric and Adult Patients with Hematological Malignancies
por: Clements, John David, et al.
Publicado: (2019)

Blinatumomab-induced T cell activation at single cell transcriptome resolution
por: Huo, Yi, et al.
Publicado: (2021)

Administration of Vancomycin at High Doses in Patients with Post Neurosurgical Meningitis: A Comprehensive Comparison between Continuous Infusion and Intermittent Infusion
por: Taheri, Morteza, et al.
Publicado: (2018)

Determination of the minimum infusion rate of alfaxalone during its co-administration with midazolam in goats
por: Dzikiti, T. B., et al.
Publicado: (2015)

Effects of intraoperative single bolus fentanyl administration and remifentanil infusion on postoperative nausea and vomiting
por: Lim, Hyungsun, et al.
Publicado: (2016)

Errors and discrepancies in the administration of intravenous infusions: a mixed methods multihospital observational study
por: Lyons, Imogen, et al.
Publicado: (2018)

Outcomes of Intravenous Push versus Intermittent Infusion Administration of Cefepime in Critically Ill Patients
por: Smith, Susan E., et al.
Publicado: (2023)

Preventive Effect of 3‐Aminobenzamide on the Reduction of NAD Levels in Rat Liver Following Administration of Diethylnitrosamine
por: Uchida, Kazuhiko, et al.
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_ojfqtpo86nrg1hmi7g3jt2j1ep